Organigram Announces Appointment of Greg Guyatt as Chief Financial Officer
18 Dezembro 2023 - 8:00AM
Business Wire
Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX:
OGI) (NASDAQ: OGI) is pleased to announce that Greg Guyatt CPA, CA,
formerly of Phoena Holdings Inc. (“Phoena”), has been appointed to
the role of Chief Financial Officer effective January 8, 2024. Mr.
Guyatt will lead Organigram’s Finance and IT divisions and will
report directly to Beena Goldenberg, Organigram’s Chief Executive
Officer.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20231218771633/en/
Greg Guyatt (Photo: Business Wire)
Mr. Guyatt is a seasoned financial executive with over 25 years
of international public company and private equity backed company
experience. He joined Phoena as Chief Financial Officer in 2019
before assuming the position of Chief Executive Officer in 2020.
Prior to joining Phoena, Mr. Guyatt was Chief Financial Officer of
Greenspace Brands and held various progressive senior finance
positions at Kingsett Capital and Sears Canada.
“I am pleased to welcome Greg to the Organigram executive
management team,” said Beena Goldenberg, CEO of Organigram. “Greg
brings tremendous experience to the team and will be a valuable
contributor to the Company as we focus on Organigram’s ambitious
growth plans with a core objective of delivering bottom-line
results.”
Mr. Guyatt replaces Paolo De Luca who had stepped in as Interim
Chief Financial Officer following the departure of Derrick West in
November. The Company thanks Paolo for his support and looks
forward to him dedicating his focus as Chief Strategy Officer which
includes leading the Jupiter initiatives following the announcement
of the proposed follow-on investment by BAT.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select Market and
TSX listed company whose wholly owned subsidiaries include
Organigram Inc. a licensed producer of cannabis, cannabis-derived
products and cannabis infused edibles in Canada. Organigram is
focused on producing high-quality cannabis for patients and adult
recreational consumers, as well as developing international
business partnerships to extend its global footprint. Organigram
has also developed and acquired a portfolio of legal adult-use
recreational cannabis brands, including Edison, Holy Mountain, Big
Bag O’ Buds, SHRED, SHRED’ems, Monjour, Laurentian, Tremblant
Cannabis and Trailblazer. Organigram operates facilities in
Moncton, New Brunswick and Lac-Supérieur, Quebec, with a dedicated
edibles manufacturing facility in Winnipeg, Manitoba. The Company
is regulated by the Cannabis Act and the Cannabis Regulations
(Canada).
Forward-Looking Information
This news release contains forward-looking information. Often,
but not always, forward-looking information can be identified by
the use of words such as “plans”, “expects”, “estimates”,
“intends”, “anticipates”, “believes” or variations of such words
and phrases or state that certain actions, events, or results
“may”, “could”, “would”, “might” or “will” be taken, occur or be
achieved. Forward-looking information involves known and unknown
risks, uncertainties and other factors that may cause actual
results, events, performance or achievements of Organigram to
differ materially from current expectations or future results,
performance or achievements expressed or implied by the
forward-looking information contained in this news release. Risks,
uncertainties and other factors involved with forward-looking
information could cause actual events, results, performance,
prospects and opportunities to differ materially from those
expressed or implied by such forward-looking information include
changes to market conditions, consumer preferences and regulatory
climate, and factors and risks as disclosed in the Company’s most
recent annual information form, management’s discussion and
analysis and other Company documents filed from time to time on
SEDAR+ (see www.sedarplus.ca) and filed or furnished to the
Securities and Exchange Commission on EDGAR (see www.sec.gov).
Readers are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date of this
press release. Although the Company believes that the assumptions
and factors used in preparing the forward-looking information in
this news release are reasonable, undue reliance should not be
placed on such information and no assurance can be given that such
events will occur in the disclosed time frames or at all. The
forward-looking information included in this news release are made
as of the date of this news release and the Company disclaims any
intention or obligation, except to the extent required by law, to
update or revise any forward-looking information, whether as a
result of new information, future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231218771633/en/
For Media enquiries: Megan McCrae, Senior Vice President
– Marketing and Communications megan.mccrae@organigram.ca
For Investor Relations enquiries: Max Schwartz, Director
of Investor Relations investors@organigram.ca
Organigram (NASDAQ:OGI)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Organigram (NASDAQ:OGI)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024